Clinical Trial Period

• Entry Criteria

  • HCV RT-PCR positive/anti-HCV negative/ALT normal (22 eligible/ 13 enrolled)
  • HIV (4 eligible / 2 enrolled)

• Donors were followed for six months and monitored for seroconversion or P24 positivity.

  
  

Previous slide

Next slide

Back to first slide

View graphic version